A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer

Clinical trial NCT07227831 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07227831
Sponsor: Barbara Ann Karmanos Cancer Institute
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

HER2-negative Breast Cancer Hormone Receptor Positive Tumor Advanced Breast Cancer Metastatic Breast Cancer

Start date: 2026-02-01
Primary completion: 2027-05-22
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.